Nephrotoxicity - What's the Point of a Course of Genomized?

There was a lot of concern when we moved over this that we were going to have like this massive increase in dialysis rates and people's kidneys were going to get completely screwed with these, these courses. But because we've kept the courses short, when you look at the sort of before and after they're introduced by trust, the rates of AKI-1 according to K-digo categorizations, that's kind of crattening loss of about maybe 20 to 40%. And if you're just using short little tiny courses like what we're doing, there's no problem really. You just need to watch their crattening in the moment. For that reason, our monitoring is